MD BCh - Aptinyx Pres CEO

APTXDelisted Stock  USD 0.07  0.01  16.67%   

Insider

MD BCh is Pres CEO of Aptinyx
Age 46
Phone847 871 0377
Webhttps://www.aptinyx.com

Aptinyx Management Efficiency

The company has return on total asset (ROA) of (0.5135) % which means that it has lost $0.5135 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.3806) %, meaning that it created substantial loss on money invested by shareholders. Aptinyx's management efficiency ratios could be used to measure how well Aptinyx manages its routine affairs as well as how well it operates its assets and liabilities.
Aptinyx currently holds 22.11 M in liabilities with Debt to Equity (D/E) ratio of 0.39, which is about average as compared to similar companies. Aptinyx has a current ratio of 15.9, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Aptinyx's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

INSIDER Age

DSc FRCPsychAdial Pharmaceuticals
62
Eugene JiangABVC Biopharma
38
Gary HattersleyNuvation Bio
57
Christopher OgdenCytomX Therapeutics
40
Sergey YurasovNuvation Bio
51
CPA CPAAditxt Inc
56
Kerry WentworthNuvation Bio
51
Howard MDABVC Biopharma
67
Tomasz GeorgeVirax Biolabs Group
40
Sumita JDInstil Bio
50
Anna MooreTranscode Therapeutics
62
Dr IVAssembly Biosciences
52
Robert CouttsAchilles Therapeutics PLC
40
David HanleyNuvation Bio
54
MBA MDSpero Therapeutics
43
Adam ZlotnickAssembly Biosciences
N/A
Susannah WalpoleSpero Therapeutics
N/A
Sandeep MDInstil Bio
55
Oleg NodelmanNuvation Bio
44
Julia WilsonAchilles Therapeutics PLC
N/A
Thomas CPAAditxt Inc
51
Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. Aptinyx Inc. was incorporated in 2015 and is headquartered in Evanston, Illinois. Aptinyx operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 40 people. Aptinyx (APTX) is traded on NASDAQ Exchange in USA and employs 12 people.

Management Performance

Aptinyx Leadership Team

Elected by the shareholders, the Aptinyx's board of directors comprises two types of representatives: Aptinyx inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Aptinyx. The board's role is to monitor Aptinyx's management team and ensure that shareholders' interests are well served. Aptinyx's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Aptinyx's outside directors are responsible for providing unbiased perspectives on the board's policies.
Kathryn King, VP Operations
Norbert Riedel, President CEO, Director
Patrick Flavin, Sr Relations
Molly Dir, VP HR
Ashish Khanna, Chief Business Officer
Harald MD, VP Affairs
Tim Noffke, VP Staff
MD BCh, Pres CEO

Aptinyx Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Aptinyx a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Consideration for investing in Aptinyx Stock

If you are still planning to invest in Aptinyx check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aptinyx's history and understand the potential risks before investing.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Transaction History
View history of all your transactions and understand their impact on performance
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Global Correlations
Find global opportunities by holding instruments from different markets